Overview

Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration

Status:
Unknown status

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess changes in serum levels of the siderophore binding protein NGAL by hemodialysis without and with intravenous iron administration

Phase:

N/A

Details

Lead Sponsor:

Soroka University Medical Center

Treatments:

Ferric Compounds
Ferric gluconate
Ferric Oxide, Saccharated
Iron